Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Arthritis Care & Research|November 17, 2020
Core Set of Domains for Outcome Measures in Behçet's SyndromeGülen Hatemi, Alexa Meara, Yesim Özgüler, et al.
Rheumatology International|August 17, 2010
Risk factors for avascular bone necrosis in patients with systemic lupus erythematosusMehmet Sayarlioglu, Nergis Yuzbasioglu, Murat Inanc, et al.
Rheumatology International|May 7, 2025
Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational studyMurat Bektaş, Burak Ince, Sibel Zaralı, et al.
The Journal of Rheumatology|September 17, 2015
Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014Gulen Hatemi, Yesim Ozguler, Haner Direskeneli, et al.
Rheumatology (Oxford, England)|September 22, 2023
Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from TurkeyMurat Bektas, Nevzat Koca, Emin Oguz, et al.
American Journal of Blood Research|May 23, 2022
Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathySevgi Kalayoglu Besisik, Murat Ozbalak, Yavuz Burak Tor, et al.
American Journal of Blood Research|April 2, 2021
Initial complete blood count score and predicting disease progression in COVID-19 patientsMurat Ozbalak, Sevgi Kalayoglu Besisik, Yavuz Burak Tor, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 25, 2015
The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosisGozde Yildirim Cetin, Eda Ganiyusufoglu, Dilek Solmaz, et al.
The Journal of Rheumatology|June 17, 2015
Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12Sibel Zehra Aydin, Haner Direskeneli, Antoine Sreih, et al.
Pageof 13